KB Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

KB Financial Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$103K	Sell	296 -13	-4%	-$4.55K	0.03%	191
2023 Q2	$109K	Sell	309 -1,112	-78%	-$375K	0.03%	200
2023 Q1	$448K	Buy	1,421 +136	+11%	+$40.8K	0.13%	104
2022 Q4	$371K	Sell	1,285 -8	-0.6%	-$2.44K	0.13%	120
2022 Q3	$374K	Buy	1,293 +214	+20%	+$61.6K	0.13%	109
2022 Q2	$304K	Sell	1,079 -156	-13%	-$41.8K	0.11%	121
2022 Q1	$322K	Buy	1,235 +98	+9%	+$23.3K	0.09%	129
2021 Q4	$250K	Buy	+1,137	New	+$221K	0.07%	157
2021 Q3	–	Sell	-13	Closed	-$3K	–	554
2021 Q2	$3K	Hold	13	–	–	﹤0.01%	530
2021 Q1	$3K	Buy	+13	New	+$2.85K	﹤0.01%	542

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KB Financial Partners's VRTX Position: Q3 2023 in Review

KB Financial Partners reduced its Vertex Pharmaceuticals (VRTX) stake by 4.2% in Q3 2023, selling an estimated $4.55K and leaving 296 shares worth $103K. The position accounts for 0.03% of the portfolio, ranked #191.

KB Financial Partners first reported a position in VRTX in Q1 2021 and has held it in 10 quarters since. The position peaked at $448K in Q1 2023. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

KB Financial Partners held 296 shares of Vertex Pharmaceuticals worth $103K as of Q3 2023.
KB Financial Partners sold 13 Vertex Pharmaceuticals shares in Q3 2023, an estimated $4.55K.
Vertex Pharmaceuticals made up 0.03% of KB Financial Partners's portfolio in Q3 2023, its #191 holding.
KB Financial Partners first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
KB Financial Partners's Vertex Pharmaceuticals position peaked at $448K in Q1 2023.
1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.